glp-1/gip/glucagon receptor agonist Review Article: GLP‐1 Agonists and Glucagon/GIP/GLP‐1 Receptor Dual or Triple Agonists—Mechanism of Action and Emerging Therapeutic Landscape in MASLD of the direct and indirect

EMEA-003258-PIP02-23 paediatric investigation plan

Effects of ethanol consumption on chromatin condensation and DNA integrity of epididymal spermatozoa in rat

Phase III results for retatrutide are set to be released later in 2025 and in early 2026, but an earlier phase II trial recorded between a 7.2% and 17.5% reduction in body weight after 24 weeks, depending on the dose (7.2% on 1mg, 17.5% on 12mg), and up to a 24.2% reduction in body weight after 48 weeks for those on 12mg (-8.7% change for those on 1mg) 8

[6] [7] In adults, low concentrations are generally tolerated, but the diluent used for any injectable must always be the one specified by the product's sponsor or manufacturer

It's not a one-size-fits-all solution, and it's certainly not a magic bullet